FUSION PROTEIN COMPRISING CD80 EXTRACELLULAR DOMAIN AND ANTI-LAG3 ANTIBODY FRAGMENT AND… Application WO-2023136518-A1 World Intellectual Property Organisation (WIPO) 20 Jul 2023
Anticorpo ricombinante umano contro il recettore di membrana LAG3, suoi usi medici e… N/A IT-201900011676-A1 Italy 12 Jan 2021